3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neuroendocrine Tumors
35
Pheochromocytoma
14
Pituitary Neoplasms
12
Thyroid Neoplasms
11
Carcinoma, Neuroendocrine
11
Thyroid Cancer, Papillary
9
Adrenocortical Carcinoma
9
Sarcoma
8
Paraganglioma
8
Adrenal Gland Neoplasms
7
Small Cell Lung Carcinoma
6
Neuroblastoma
6
Cushing Syndrome
6
Parathyroid Neoplasms
5
Ovarian Neoplasms
5
Neoplasms
5
Carcinoma, Medullary
5
Carcinoid Tumor
5
Pancreatic Neoplasms
4
Osteosarcoma
4
Multiple Endocrine Neoplasia Type 1
4
Meningioma
4
Insulinoma
4
Cholangiocarcinoma
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Adenoma, Islet Cell
4
Adenocarcinoma, Follicular
4
Thyroid Carcinoma, Anaplastic
3
Interventions
Iodine-124
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Differentiated Thyroid Carcinoma
×
Endocrine
×
30 days
×
Clear all
NCT01704586
2026-05-12
CLERAD-PROBE
University of Wuerzburg
Phase NA
Active not recruiting
340 enrolled